Numerous studies have suggested that excess body weight is associated with increased cancer risk. To examine this putative association, we performed a systematic review and quantitative meta-analysis of cohort studies reporting body mass index (BMI) and the risk of 23 cancer types. PubMed, Embase, and Web of Science were searched for cohort studies, yielding 325 articles with 1,525,052 cases. Strong positive associations were observed between BMI and endometrial cancer (RR: 1.48), esophageal adenocarcinoma (RR: 1.45), and kidney cancer (RR: 1.20); weaker associations (RR < 1.20) were also found for several other cancer types. Interestingly, we found significant inverse associations between BMI and oral cavity (RR: 0.93), lung (RR: 0.91), premenopausal breast (RR: 0.95), and localized prostate (RR: 0.97) cancers. A male-specific association was found for colorectal cancer (p 5 0.023), and a female-specific association was found for cancer in brain (p 5 0.025) or kidney (p 5 0.035). With respect to geography, the strongest positive association was found for total cancer in North America (p 5 0.038). This comprehensive meta-analysis provides epidemiological evidence supporting the association between BMI and cancer risk. These findings can be used to drive public policies and to help guide personalized medicine in order to better manage body weight, thereby reducing the risk of developing obesity-related cancer.
Introduction
Changes in our lifestyle over the past few decades have led to a significant increase in the worldwide prevalence of both overweight (defined as a body mass index [BMI] 25 kg/m 2 ) and obesity (BMI 30 kg/m 2 ), thus representing a significant public health issue. 1, 2 According to recent studies, the global prevalence of overweight and obesity among adults increased by >25% from 1980 to 2013; thus, 34.4% of all adults are currently overweight, and 12.0% of adults are classified as obese. 1, 3 Given these alarming statistics, understanding the effects of overweight and obesity on various health parameters is considered a high priority. High BMI is associated with adipose tissue dysfunction, which increases the risk of developing Type 2 diabetes and/ or cardiovascular disease. [4] [5] [6] [7] In addition, high BMI is increasingly recognized as an important risk factor for developing several types of cancers. [8] [9] [10] For example, a large populationbased cohort study of 5.24 million adults in the United Kingdom recently reported significant associations between BMI and 22 specific cancer types. 11 In addition, the Global Burden of Disease (GBD) study recently estimated that obesity may account for the increasing global incidence of cancer-related mortality. 12 Despite clear indications that BMI is related to the risk of developing cancer, the most recent systemic meta-analysis of this association was conducted back in 2008 by Renehan et al. 13 in which the authors reported associations between BMI and 20 cancer types. Specifically, they reported that higher BMI was associated with an increased risk of the following seven types of cancers in both males and females: thyroid, kidney, and colorectal cancers, esophageal adenocarcinoma, multiple myeloma, leukemia, and nonHodgkin's lymphoma. They also reported an increased risk of melanoma and rectal cancer among men, and they reported an increased risk of endometrial, postmenopausal breast, gallbladder, and pancreatic cancers among women. 13 Since 2008, many association studies have linked BMI to various cancer types; therefore, we performed a dose-response meta-analysis of published epidemiological evidence spanning all existing prospective cohort studies in order to provide an updated analysis of both the linear and non-linear associations between BMI and the risk of developing specific cancer types.
Methods
This meta-analysis was designed, implemented, and analyzed in accordance with the Meta-Analysis of Observational Studies in the Epidemiology (MOOSE) protocol 14 and is reported in accordance with PRISMA guidelines.
14,15
Search strategy and selection criteria
We systematically searched Medline (PubMed), Embase, and Web of Science for prospective cohort studies published through November 1, 2016. The following key words were used in our search: (obesity OR adiposity OR overweight OR "body mass index" OR "body size") AND (cancer OR carcinoma OR neoplasia OR tumor OR neoplasm OR malignancy) AND (cohort OR "prospective study" OR "follow-up study" OR "longitudinal study"). Our search was restricted to studies conducted in humans, and no restrictions were imposed regarding the language in which the studies were published. The references within the retrieved relevant articles-in particular, published meta-analyses-were also reviewed in order to identify additional studies.
Studies that met the following four criteria were included in our meta-analysis: (i) prospective study design; (ii) the exposure of interest was BMI; (iii) the outcome was the risk of cancer; and (iv) the authors reported risk estimates (with 95% confidence intervals) for at least three quantitative categories of BMI. We excluded reviews, meta-analyses, retrospective studies, and published letters that lacked sufficient data. To ensure that we identified all eligible studies, we used a two-step selection process. 16 First, two independent investigators (authors X.F. and J.W.) initially screened all titles and abstracts; second, these two authors evaluated all potentially relevant papers based on a review of the full-text articles.
Data extraction
Data were extracted using a standardized data collection form. Two investigators (authors J.W. and X.H.) independently extracted detailed information from each included article. Discrepancies were resolved through group discussion with a third investigator (author X.F.). We extracted the following information from each study: first author of the publication, year of publication, study location, study name (where applicable), duration of follow-up, gender, sample size (i.e., the number of cases and/or participants), BMI categories, and the corresponding risk estimates (with 95% confidence intervals). We extracted the risk estimates with the most adjustment. Quality assessment was performed using the NewcastleOttawa scale for non-randomized studies. 17 This scale assigns a maximum of nine points to each study: four points for the selection of participants and measurement of exposure, two points for comparability, and 3 points for the assessment of outcomes and adequacy of follow-up. We regarded scores of 0-3, 4-6, and 7-9 as representing low, moderate, and high quality, respectively.
Statistical analysis
In this meta-analysis, relative risk (RR) and the 95% confidence interval (CI) were considered the effect size for all studies; where applicable, the hazard ratio was deemed equivalent to RR. 18 Any results that were stratified by gender were pooled using a fixed effects meta-analysis before inclusion in the overall meta-analysis.
A dose-response analysis between BMI and cancer risk was performed using the method described by Greenland What's new? Recent studies have uncovered a startling rise in global prevalence of overweight and obesity among adults since the 1980s, raising new concerns about associations between obesity and cancer risk. The authors of the present study reassessed associations between obesity and different cancers. Analyses revealed positive associations between body mass index (BMI) and multiple cancer types, with several gender-specific and geography-specific associations. Geographically, the strongest positive association between obesity and total cancer was in North America. The findings, which are relevant for public health, could also help guide personalized efforts to improve body weight management and thereby reduce cancer risk.
and Longnecker 20 and the publicly available Stata command written by Orsini et al. 19, 20 The categories of BMI, distributions of cases and person-years, RR, and 95% CI were extracted using this method. If the number of cases and/or person-years was not available, variance-weighted least squares regression was used to achieve the pooled risk estimate. 21, 22 If neither median nor mean values were reported, we used the categorical midpoint. If the highest or lowest category was open-ended, the midpoint of the category was estimated by assuming that the width of the category was the same as the next adjacent category. 23 In addition, we evaluated potential non-linear associations between BMI and cancer risk using restricted cubic splines with three knots at the 10th, 50th, and 90th percentiles of the distribution. 24 And the analyses were re-scaled so the reference category was a BMI of 20. A p values for curve linearity or non-linearity was calculated by testing the null hypothesis that the coefficient of the second spline was equal to zero.
Restricted maximum likelihood-based random-effects meta-regression was performed in order to examine the effect of differences in RR between various subgroups, including gender (male vs. female), case type (incidence vs. mortality), and study location (North America vs. Europe vs. AsiaPacific). 25, 26 We used a pre-specified random-effects model for our analysis in order to account for the RR between BMI and total cancer in various countries; these results are depicted using a cartogram.
Heterogeneity among the studies was estimated using the I 2 statistic, with values of 25%, 50%, and 75% representing low, moderate, and high degrees of heterogeneity, respectively. 27, 28 Publication bias was evaluated using contourenhanced funnel plots, 29 Egger's linear regression test, 30 and Begg's rank association test, with significance defined as p < 0.10.
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All statistical analyses were performed using Stata version 12 and RStudio. Except where noted otherwise, differences with a p values <0.05 were considered significant.
Results

Literature search and study characteristics
Our initial search identified a total of 7067 articles in PubMed, 6845 articles in Embase, and 6,937 articles in Web of Science (Fig. 1 ). After we excluded duplicates and studies that did not meet our inclusion criteria, 1,032 articles were deemed to be potentially relevant for our study. Based on the four inclusion criteria listed in the Methods, a total of 319 articles were included for the analysis. In addition, 11 studies were identified from the reference lists in previously published reviews and meta-analyses. Thus, a total of 325 publications of prospective cohort studies were included in this meta-analysis. Detailed characteristics of the included cohort studies are presented in Supporting Information Table S1 . The mean study quality score was 8.2, and most of the studies had a score 5 (representing moderate or high quality; Supporting Information Table S2 ). In addition, excluded studies are listed in Supporting Information Table S3 with the reasons for exclusion. Table 1 summarizes the characteristics of the studies included in the analysis. During the follow-up period, which ranged from 4 to 30 years, we identified a total of 1,525,052 worldwide incident cases and deaths associated with 23 tissue-specific cancers. Notably, no data were available from North America contributing to the summary of either esophageal squamous cell carcinoma or biliary tract cancer.
Association between each 5 kg/m 2 increase in BMI and the risk of cancer
After we included BMI as a linear effect and adjusted for major potential confounders such as age, gender, and ethnicity, we found that each 5 kg/m 2 increase in BMI was associated with a moderate increase in the overall risk of cancer ( Fig. 2 and Supporting Information Table S4 ). When we examined each specific cancer type, we found that increased BMI was positively associated with cancers occurring in a wide range of organs and/or tissues (Fig. 2) . On the other hand, we found inverse associations between BMI and several cancer types, including oral, esophageal squamous cell, lung, premenopausal breast, and localized prostate cancers (Fig. 2) . Between-study heterogeneity was low for biliary tract and thyroid cancers, but moderate or high for the other cancer sites. Forest plots for each cancer site are shown in Figure 1 . Flowchart depicting the literature search and selection strategy.
Cancer Epidemiology
Fang et al.
Supporting Information Figures S1-S33. Similar results were obtained when we repeated our analyses using a fixed-effects model rather than a random-effects model (Supporting Information Table S5 ).
Non-linear dose-response analyses
Next, we performed a non-linear dose-response analysis in order to determine whether BMI and cancer risk have a nonlinear association. Our analysis revealed a non-linear relationship between increasing BMI and the overall risk of cancer (Fig. 3a) . The positive and inverse non-linear relationships between each specific cancer type are summarized in Figures  3b and 3c , respectively. With respect to the association between BMI and biliary tract, gallbladder, thyroid, bladder, and oral cancers, we found a linear relationship, but not a significant non-linear relationship (data not shown). In addition, we found no significant difference between the linear and non-linear dose-response analyses with respect to other cancer types.
Subgroup analyses: gender
Next, we performed several subgroup analyses based on gender, incidence versus mortality, and study location. We found that males and females differed with respect to the association between increased BMI and colorectal, kidney, and brain cancers (Table 2 and Supporting Information 
Subgroup analyses: cancer incidence versus mortality
Several cohort studies identified either cancer incidence or mortality as the study endpoint. Table 3 and Supporting  Information Table S7 summarized the effect of increasing BMI on either the incidence of overall and site-specific cancers or mortality. With respect to prostate cancer (RR: 1.11; 95% CI: 1.06, 1.15) and non-Hodgkin's lymphoma (RR: 1.12; 95% CI: 1.06, 1.19), the association was generally stronger in studies that reported mortality rather than incidence.
Subgroup analyses: study location
Lastly, we examined whether the associations differed between cancer sites for which we had at least two datasets from the main geographic regions analyzed. For most cancer types, the association between increased BMI and risk was similar among geographic regions (Supporting Information  Table S8 ). However, we found that the associations between BMI and risk of total cancer (RR: 1.09; 95% CI: 1.04, 1.14) were stronger in North America than in the other two regions analyzed. Specifically, we found a positive association in Korea, Sweden, the UK, Canada, and the USA, and we found an inverse association in India (Fig. 4) .
Publication bias
Using Egger's linear regression test and the Begg's rank association test, we found no publication bias for any of the 
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associations measured between BMI and cancer risk (Supporting Information Table S9 ).
Discussion
Here, we present the most up-to-date quantitative metaanalysis and systematic estimate of the association between BMI and 23 tissue-specific cancers. Our results support the notion that increased BMI is associated with an increased risk of a subset of cancer types and shed light on the global cancer-related burden associated with high BMI. In our analysis, we included three cancer sites (the oral cavity, biliary tract, and brain) in addition to the original 20 cancer sites reported in 2008. 13 Among these 23 cancer types, 18 were positively associated with BMI. Consistent with previous reports, the strongest positive association was found between BMI and endometrial cancer. [32] [33] [34] Ali recently reported that high BMI can affect both the synthesis and bioavailability of sex hormones through a variety of biological pathways. 35 Consistent with this notion, studies using hormone replacement therapy (HRT) suggest that circulating sex hormones can play a major role in the relationship between obesity and endometrial cancer. 36, 37 In contrast, we found that BMI was negatively associated with the risk of oral cavity, lung, and premenopausal breast cancers. Given that cigarette smoking strongly affects both BMI and the risk of lung cancer, it is interesting to note that Koh et al. and Bhaskaran et al. performed subgroup analysis respectively to examine this interaction and found that BMI does not affect the risk of lung cancer among non-smokers and former smokers. 11, 38 In addition, a recent meta-analysis found completely different dose-response relationship between BMI and all-cause mortality among healthy never smokers and in the overall population. 39 Nevertheless, no plausible mechanism is known for which increased body fat could potentially protect against lung cancer.
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Interestingly, increasing BMI had distinctly different effects on the risk of some forms of cancers. First, general obesity was associated with a higher risk of esophageal adenocarcinoma, which might be attributed primarily to the higher prevalence of gastroesophageal reflux among obese individuals. 41, 42 Moreover, gastroesophageal reflux is believed to predispose patients to develop Barrett's esophagus, a premalignant lesion that increases the risk of esophageal adenocarcinoma. 43 On the other hand, we observed an inverse association between BMI and esophageal squamous cell carcinoma, which may be due in part to a metabolic interplay between smoking and body mass. 42 In contrast with the 2008 review by Renehan et al. 13 our gender-stratified subgroup analysis revealed a female-specific positive association between BMI and the risk of brain cancer, but not gallbladder cancer, esophageal adenocarcinoma, or kidney cancer. This discrepancy between our results and the previous results is likely due to the large number of cases in our analysis, and it may reflect the complexity associated with the gender-specific effects of increased BMI with respect to specific cancer types. Interestingly, however, with respect to colorectal cancer, we observed a stronger positive association among men than among women.
With respect to breast cancer among women, our analysis supports previous reports that menopausal state is an important confounding factor when considering the effects of increased BMI. 44 The mechanisms that underlie the differences between premenopausal and postmenopausal women are poorly understood; 45 nevertheless, as with endometrial cancer, sex hormones (e.g., estrogen) may play a role in the association between BMI and breast cancer. 46 Interestingly, we found that BMI is inversely associated with the risk of localized prostate cancer but positively associated with the risk of advanced prostate cancer, suggesting that BMI has opposing effects on the development of prostate cancer subtypes. This contrasting effect may be attributed to lower concentrations of free testosterone in obese men, which is paradoxically associated with both a decreased risk of localized prostate cancer and an increased risk of advanced prostate cancer. 47, 48 Notably, we found a significant association between BMI and total cancer risk in North America, but not in European and Asia-Pacific countries. This difference between geographic regions suggests that common dietary patterns and/ or lifestyles within these populations may play a role in the interaction between adipocytes and the progression of cancer. For example, the prevalence of smoking among men is much higher in some Asian countries than in Europe and North America. 49 Although the prevalence of cancer varies around the globe, insufficient information is currently available regarding the rate of cancer in many underdeveloped and economically transitioning countries. Therefore, the factors that underlie these gender-specific and geography-specific differences warrant further study.
Interestingly, we found that mortality associated with-but not the incidence of-prostate cancer and non-Hodgkin's lymphoma is significantly associated with BMI. Consistent with this finding, epidemiological evidence suggests that BMI affects mortality among cancer patients. For example, high BMI is more strongly associated with the risk of mortality among younger men than among older men. [50] [51] [52] Moreover, a meta-analysis of the effect of BMI on mortality among elderly non-smoking women over 65 years of age found that obesity significantly increases the risk of mortality. 53, 54 Based on these findings, future studies are clearly needed in order to further dissect the role of high BMI in increased mortality among patients with prostate cancer and non-Hodgkin's lymphoma.
Our study has several limitations that warrant discussion. First, because of the observational nature of the studies included in our analysis, residual confounding factors cannot be excluded, including the inherent issues associated with the original studies. For example, many of the studies measured BMI using self-reported height and weight data. Although increasing evidence suggests that self-reported data provide a reliable measure of BMI, further studies might be needed in order to assess the effect of quantitative body fat distribution on cancer risk. Secondly, we may have missed age-dependent effects combined with other risk factors; however, such effects are unlikely, as our age-stratified subgroup analysis did not yield any significant associations between BMI and cancer risk. Finally, we found high heterogeneity (defined as I 2 > 75%) in 11 of the 23 cancer types analyzed, and such high heterogeneity cannot be explained by most of our subgroup analyses.
The mechanisms by which high BMI affects the risk of certain cancer types remain poorly understood. However, several factors have been suggested, including obesity-related inflammation, adipocyte-derived cytokines, sex hormones, and the insulin-IGF-1 axis. 10, 55 Adipose tissue is an integral component of the tumor's microenvironment and affects the growth, metastasis, and recurrence of cancer cells. 56, 57 Moreover, obesity has been linked to chronic inflammation by increasing the secretion of cytokines and other factors, including leptin, IL-2, IL-6, IL-8, and TNF-a. 58 In the nearly 10 years since Renehan et al. published their meta-analysis regarding the association between BMI and cancer, 13 many relevant epidemiological studies have been reported. As a result, our meta-analysis included many more articles (324 vs. 141) and incident cases (1,562,959 vs. 282,137) than the previous meta-analysis. 13 Moreover, our comprehensive dose-response meta-analysis focuses on prospective cohort studies from large populations based on geographic region. In addition, our analysis had sufficient power to detect moderate-and even weak-associations, as the combined sample size was extremely large and the follow-up period was relatively long. Furthermore, to minimize the effects of potential confounding factors, we used estimates from the fully adjusted models in our analyses. Lastly, to identify potential sources of heterogeneity and to evaluate robustness, we conducted stratified analyses based on gender, case type, and geographic location.
Conclusions
In summary, the results obtained from our comprehensive quantitative analyses provide strong epidemiological evidence supporting the general notion that excess body weight-and obesity in particular is a major risk factor for certain types of cancers. Therefore, the current global trend of increasing overweight and obesity will likely contribute to the increasing global prevalence of cancer. From a public health perspective, it is therefore important to recognize that controlling body weight is one of the most effective methods of reducing the susceptibility for developing cancer.
